麦澜德股价跌5.02%，汇添富基金旗下1只基金位居十大流通股东，持有36.38万股浮亏损失80.04万元

Group 1 - The core point of the article highlights the recent decline in the stock price of Mylande, which fell by 5.02% to 41.63 CNY per share, with a trading volume of 63.59 million CNY and a turnover rate of 4.08%, resulting in a total market capitalization of 4.163 billion CNY [1] - Mylande Medical Technology Co., Ltd. specializes in the research, development, production, sales, and services related to pelvic floor and postpartum rehabilitation products, with its main business revenue composition being 36.98% from pelvic rehabilitation products, 33.10% from reproductive rehabilitation products, 24.32% from consumables and accessories, 2.77% from sports rehabilitation products, and 2.18% from other supplementary products [1] Group 2 - Among Mylande's top ten circulating shareholders, a fund under Huatai PineBridge holds a position, having reduced its holdings by 29.94 thousand shares in the second quarter, now holding 36.38 thousand shares, which accounts for 0.99% of the circulating shares [2] - The Huatai Growth Focus Mixed Fund (519068) has a total asset size of 2.851 billion CNY and has achieved a year-to-date return of 18.61%, ranking 4578 out of 8160 in its category, with a one-year return of 15.36%, ranking 5161 out of 8021 [2]